BAY-3713372

N/A

Report date: 2026/03/24 20:00:35
NME

Base Information

Drug NameBAY-3713372
Drug Alias NameBAY-3713372PH020PH-020PH-020-803
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein arginine methyltransferase 5 inhibitors
TargetsProtein arginine methyltransferase 5
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[14] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSuzhou Puhe Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBayer AGSuzhou Puhe Pharmaceutical Technology Co LtdBayer Healthcare Company Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A